Essential functions of p21-activated kinase 1 in morphogenesis and differentiation of mammary glands

Journal of Cell Biology

Volumn 161, Issue 3, 2003, Pages 583-592

  Wang, Rui An ^a   Vadlamudi, Ratna K ^a   Bagheri Yarmand, Rozita ^a   Beuvink, Iwan ^a   Hynes, Nancy E ^b   Kumar, Rakesh ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

Mammary gland; Milk proteins; Morphogenesis; Pak1; Stat5

Indexed keywords

ACID PROTEIN; ALANINE; BETA CASEIN; BETA LACTOGLOBULIN; P21 ACTIVATED KINASE 1; PROTEIN SERINE THREONINE KINASE; SERINE; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; GENE DELETION; MAMMARY GLAND; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TRANSGENE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CASEINS; CELL DIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; DNA-BINDING PROTEINS; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; LACTATION; MAMMARY GLANDS, ANIMAL; MICE; MICE, TRANSGENIC; MILK PROTEINS; MUTATION; PHOSPHORYLATION; PREGNANCY; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; SERINE; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSGENES;

ANIMALIA; MUS MUSCULUS; OVIS;

EID: 0037936545     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200212066     Document Type: Article

References (46)

1. Adam, L., R. Vadlamudi, S.B. Kondapaka, J. Chernoff, J. Mendelsohn, and R. Kumar. 1998. Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-I via phosphatidylinositol-3 kinase. J. Biol. Chem. 273:28238-28246.
2. Adam, L., R. Vadlamudi, M. Mandal, J. Chernoff, and R. Kumar. 2000. Regulation of microfilament reorganization and invasiveness of breast cancer cells by p21-activated kinase-I K299R. J. Biol. Chem. 275:12041-12050.
3. Baeckstrom, D., D. Alford, and J. Taylor-Papadimitriou. 2000. Morphogenetic and proliferative responses to heregulin of mammary epithelial cells in vitro are dependent on HER2 and HER3 and differ from the responses to HER2 homodimerisation or hepatocyte growth factor. Int. J. Oncol. 16:1081-1090.
4. Bagheri-Yarmand, R., M. Mandal, A.H. Taludker, R.A. Wang, R.K. Vadlamudi, H.J. Kung, and R. Kumar. 2001. Etk/Bmx tyrosine kinase activates Pak1 and regulates tumorigenicity of breast cancer cells. J. Biol. Chem. 276:29403-29409.
5. Bagrodia, S., and R.A. Cerione. 1999. Pak to the future. Trends Cell Biol. 9:350-355.
6. Beuvink, I., D. Hess, H. Flotow, J. Hosteenge, B. Groner, and N.E. Hynes. 2000. Stat5a serine phophsphorylation. Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity. J. Biol. Chem. 275:10247-10255.
7. Chodosh, L.A., H.P. Gardner, J.V. Rajan, D.B. Stairs, S.T. Marquis, and P.A. Leder. 2000. Protein kinase expression during murine mammary development. Dev. Biol. 219:259-276.
8. David, M., L. Wong, R. Flavell, S.A. Thompson, A. Wells, A.C. Larner, and G.R. Johnson. 1996. STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J. Biol. Chem. 271:9185-9188.
9. Fowler, K.J., F. Walker, W. Alexander, M.L. Hibbs, E.C. Nice, R.M. Bohmer, G.B. Mann, C. Thumwood, R. Maglitto, J.A. Danks, et al. 1995. A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl. Acad. Sci. USA. 92:1465-1469.
10. Gallego, M.I., N. Binart, G.W. Robinson, R. Okagaki, K.T. Coschigano, J. Perry, J.J. Kopchick, T. Oka, P.A. Kelly, and L. Hennighausen. 2001. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev. Biol. 229:163-175.
11. Hennighausen, L., G.W. Robinson, K.U. Wagner, and X. Liu. 1997. Developing a mammary gland is a stat affair. J. Mammary Gland Biol. Neoplasia. 2:365-372.
12. Hennighausen, L., and G.W. Robinson. 2001. Signaling pathways in mammary gland development. Dev. Cell. 1:467-475.
13. Howe, A.K., and R.L. Juliano. 2000. Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase. Nat. Cell Biol. 2:593-600.
14. Jones, F.E., and D.F. Stern. 1999. Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation. Oncogene. 18:3481-3490.
15. Jones, F.E., D.J. Jerry, B.C. Guarino, G.C. Andrews, and D.F. Stern. 1996. Hetegulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Differ. 7:1031-1038.
16. Jones, F.E., T. Welte, X.Y. Fu, and D.V. Stern. 1999. Erb4 signaling in the mammary gland is required for lobulo-alveolar development and Stat5 activation during lactation. J. Cell Biol. 147:77-87.
17. Kazansky, A.V., E.B. Kabotyanski, S.L. Wyszomierski, M.A. Mancini, and J.M. Rosen. 1999. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5b and Stat5a. J. Biol. Chem. 274:22484-22492.
18. Kumar, R., and R.A. Wang. 2002. Protein kinases in mammary gland development and cancer. Microsc. Res. Tech. 59:49-57.
19. Kumar, R., and R.K. Vadlamudi. 2002. Emerging functions of p21-activated kinases in human cancer cells. J. Cell Physiol. 190:189-199.
20. Liu, B., M. Fang, Y. Lu, G.B. Mills, and Z. Fan. 2001. Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells. Br. J. Cancer. 85:303-311.
21. Liu, X., G.W. Robinson, K.U. Wagner, L. Garrett, A. Wynshaw-Boris, and L. Hennighausen. 1997. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 11:179-186.
22. Luetteke, N.C., T.H. Qiu, S.E. Fenton, K.L. Troyer, R.F. Riedel, A. Chang, and D.C. Lee. 1999. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126:2739-2750.
23. Lundgren, K., R. Montes de Oca Luna, Y.B. McNeill, E.P. Emerick, B. Spencer, C.R. Barfield, G. Lozano, M.P. Rosenberg, and C.A. Finlay. 1997. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Genes Dev. 11:714-725.
24. Manser, E., T. Leung, H. Salihuddin, Z.S. Zhao, and L. Lim. 1994. A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature. 367:40-46.
25. Marte, B.M., M. Jeschke, D. Graus-Porta, D. Taverna, P. Hofer, B. Groner, Y. Yarden, and N.E. Hynes. 1995. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells. Mol. Endocrinol. 9:14-23.
26. Mazumdar, A., R.A. Wang, S.K. Mishra, L. Adam, R. Bagheri-Yarmand, M. Mandal, R.K. Vadlamudi, and R. Kumar. 2001. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 cotepressor. Nat. Cell Biol. 3:30-37.
27. Medina, D. 1996. The mammary gland: a unique organ for the study of development and tumotigenesis. J. Mammary Gland Biol. Neoplasia. 1:5-19.
28. Miyoshi, K., J.M. Shillingford, G.H. Smith, S.L. Grimm, K.U. Wagner, T. Oka, J.M. Rosen, G.W. Robinson, and L. Hennighausen. 2001. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J. Cell Biol. 155:531-542.
29. Mui, A.L., H. Wakao, T. Kinoshita, T. Kitamura, and A. Miyajima. 1996. Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation. EMBO J. 15:2425-2433.
30. Nicolas, T., and A. Hall. 1997. Rho, Rac, CDC42 regulate organization of the cytoskeleton. Curr. Opin. Cell Biol. 9:86-92.
31. Niemann, C., V. Brinkmann, E. Spitzer, G. Hartmann, M. Sachs, H. Naundorf, and W. Birchmeier. 1998. Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J. Cell Biol. 143:533-545.
32. Olayioye, M.A., I. Beuvink, K. Horsch, J.M. Daly, and N.E. Hynes. 1999. ErbB receptor-induced activation of Stat transcription factors is mediated by Src Tyrosine kinases. J. Biol. Chem. 274:17209-17218.
33. Ruff-Jamison, S., K. Chen, and S. Cohen. 1995. Epidermal growth factor induces the tyrosine phosphorylation and nuclear translocation of Stat5 in mouse liver. Proc. Natl. Acad. Sci. USA. 92:4215-4218.
34. Schurmann, A., A.F. Mooney, L.C. Sanders, M.A. Sells, H.G. Wang, J.C. Reed, and G.M. Bokoch. 2000. p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. Mol. Cell. Biol. 20:453-461.
35. Sells, M.A., U.G. Knaus, S. Bagrodia, D.M. Ambrose, G.M. Bokoch, and J. Chernoff. 1997. Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr. Biol. 7:202-210.
36. Shillingford, J.M., K. Miyoshi, G.W. Robinson, S.L. Grimm, J.M. Rosen, H. Neubauer, K. Pfeffer, and L. Hennighausen. 2002. Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium. Mol. Endocrinol. 16:563-570.
37. Vadlamudi, R.K., L. Adam, R.A. Wang, M. Mandal, D. Nguyen, A. Sahin, J. Chernoff, M.C. Hung, and R. Kumar. 2000a. Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J. Biol. Chem. 275:36238-36244.
38. Vadlamudi, R., R.A. Wang, A.H. Talukder, L. Adam, R. Johnson, and R. Kumar. 2000b. Evidence of Rab3A expression, regulation of vesicle trafficking, and cellular secretion in response to heregulin in mammary epithelial cells. Mol. Cell Biol. 20:9092-9101.
39. Vadlamudi, R.K., F. Li, L. Adam, D. Nguyen, Y. Ohta, T.P, Stossel, and R. Kumar. 2002. Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase. Nat. Cell Biol. 4:681-690.
40. Wakao, H., N.M. Schmitt, and B. Groner. 1992. Mammary gland specific nuclear factor is present in lactating rodent and bovine mammary tissue and composed of a single polypeptide of 89 kDa. J. Biol. Chem. 267:16365-16370.
41. Wang, R.A., P.K. Nakane, and T. Koji. 1998. Autonomous cell death of mouse male germ cells during fetal and postnatal period. Biol. Reprod. 58:1250-1256.
42. Wang, R.A., R.A. Mazumdar, R.K. Vadlamudi, and R. Kumar. 2002. P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-α and promotes hyperplasia in mammary epithelium. EMBO J. 21:5437-5447.
43. Xie, W., A.J. Paterson, E. Chin, L.M. Nabell, and J.E. Kudlow. 1997. Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol. Endocrinol. 11:1766-1781.
44. Yamashita, H., J. Xu, R.A. Erwin, W.L. Farrar, R.A. Kirken, and H. Rui. 1998. Differential control of the phosphorylation state of ptoline-juxtaposed serine residues Ser725 of Stat5a and Set730 of Stat5b in ptolactin-sensitive cells. J. Biol. Chem. 273:30218-30224.
45. Yamashita, H., M.T. Nevalainen, J. Xu, M.J. LeBaron, K.U. Wagner, R.A. Erwin, J.M. Harmon, L. Hennighausen, R.A. Kirken, and H. Rui. 2001. Role of serine phosphorylation of Stat5a in prolactin-stimulated β-casein gene expression. Mol. Cell. Endocrinol. 183:151-163.
46. Yang, Y., E. Spitzer, D. Meyer, M. Sachs, C. Niemann, G. Hartmann, K.M. Weidner, C. Birchmeier, and W. Birchmeiet. 1995. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131:215-226.